Remove 2030 Remove Financial Market Remove Portfolio Remove Taxes
article thumbnail

Best Cancer Pharma stock in India 2024 to keep an eye on!

Trade Brains

Financially, Beta Drugs saw strong growth with revenue rising from ₹227 crore in 2023 to ₹296 crore in 2024. Its net profit also increased from ₹31 crore in 2023 to ₹36 crore in 2024, reflecting its expanding market presence. The company’s API business shows a diverse portfolio in FY24. Current Market Price ₹ 843.1

article thumbnail

Can MRPL pump up its profit like it did before? A look into its future plans

Trade Brains

until 2030. While looking at the net profit MRPL profit decreased by 10.23% because of increased payment of taxes so it came down from 2958.25 In FY 23, MRPL maintained a favourable financial metrics with a return on equity (ROE) of 31.10% and return on capital employed (ROCE) of 19.69%. crore rupees to 2655.41 crore rupees.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fundamental Analysis Of Titagarh Rail Systems – Financials & More

Trade Brains

This is poised to increase the share of railways in freight transportation from about 27% – 45% by 2030. of the country’s GDP to 8% by 2030. The table below shows the total income and net profit of Titagarh Railsystems Ltd for 5 financial years: Year Total Revenue(₹ In crores) Profit after tax (₹ In crores) 2023 2822.17

article thumbnail

Fundamental Analysis Of Servotech Power Systems – Future Plans & More

Trade Brains

The growth of the EV market is attributed to government support, environmental awareness, and technological advancements.cal advancements. Solar Industry The solar power industry in India is rapidly expanding, with an expected market value of around $238 billion by 2030, driven by a remarkable 40% CAGR between 2023 and 2032.

article thumbnail

Fundamental Analysis Of Zydus Lifesciences – Financials & More Details

Trade Brains

From 2020 to 2030, it is expected to grow at a CAGR of 12.3%. The company has plans to spend over 8% on research and development in FY24 with its major expenses incurred towards innovative portfolio. From 2016 to 2019, the Indian pharmaceutical sector increased at a compound annual growth rate (CAGR) of 6.6%. of revenues.

article thumbnail

Fundamental Analysis Of KEC International – Future Plans & More

Trade Brains

Industry Overview The total output of the global construction market was $10.7 trillion by 2030. The article concludes with a highlight of plans and a summary. trillion in 2020 and is projected to increase to $15.2 This industry is becoming a significant contributor to economic growth, with spending levels expected to reach 13.5%

article thumbnail

Turn Your Hobbies into Interesting Money-Making Investment Opportunities

WiserAdvisor

There are no lock-in periods, penalties, or complex tax considerations. Profits earned from selling sneakers are simply added to your income and taxed accordingly. This greatly simplifies the financial and tax aspects of the investment. billion by 2030. Sneaker investments also come with minimal complications.